Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum

NeuroReport

Volumn 9, Issue 1, 1998, Pages 133-136

  Schneider, J S ^a   Wade, Timothy ^a   Lidsky, T I ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Clozapine; Glutamate; Haloperidol; Neuroleptics; Reuptake; Striatum

Indexed keywords

CARRIER PROTEIN; CLOZAPINE; GLUTAMIC ACID; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; GENE EXPRESSION; GLIA; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MOTOR DYSFUNCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032484645     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199801050-00026     Document Type: Article

References (21)

1. Casey, DE. Tardive dyskinesia. In: Bloom, F and Kupfer DJ, eds. Psychopharmacology, the Fourth Generation of Progress. NY: Raven Press, 1995: 1497-1502.
2. Fitzgerald LW, Deutch AY, Gasic G et al. J Neurosci 15, 2453-2461 (1995).
3. See RE and Lynch AM. NeuroReport 6, 1795-1798 (1995).
4. Bardgett ME, Wrona CT, Newcomer JW et al. Eur J Pharmacol 230, 245-250 (1993).
5. Yamamoto BK and Cooperman MA. J Neurosci 14, 4159-4166 (1994).
6. Santiago M and Westerink BHC. Eur J Pharmacol 204, 79-85 (1991).
7. Kerkerian L, Dusticier N and Nieoullon A. J Neurochem 48, 1301-1306 (1987).
8. Filloux F and Wamsley JK. Synapse 8, 281-288 (1991).
9. Greene JG and Greenamyre JT. Prog Neurobiol 48, 613-643 (1996).
10. Schmitt A, Asan E, Puschel B, et al. Neurosci 71, 989-1004 (1996).
11. Torp R, Danbolt NC, Babaie E et al. Eur J Neurosci 6, 936-942 (1994).
12. Kuwanara O, Mitsumoto Y, Chiba K et al. J Neurochem 59, 616-621 (1992).
13. Rothstein JD, Martin LJ and Kuncl RW. N Engl J Med 326, 1464-1468 (1992).
14. Masliah E, Alford M, DeTeresa R et al. Ann Neurol 40, 759-766 (1996).
15. Rothstein JD, Jin L, Dykes-Hoberg M et al. Proc Natl Acad Sci USA 90, 6591-6595 (1993).
16. Lidsky TI, Schneider JS, Yablonsky-Alter E et al. Br Res 686, 104-106 (1995).
17. Lidsky TI and Banerjee SP. Drug News Perspect 9, 453-459 (1996).
18. Elliott PJ, Close SP, Walsh DM et al. J Neural Transm 2, 91-100 (1990).
19. See RE and Chapman MA. Eur J Pharmacol 263, 269-276 (1994).
20. Carlsson M and Carlsson A. Trends Neurosci 13, 272-276 (1990).
21. Ichikawa J and Meltzer HY. Eur J Pharmacol 176, 371-374 (1990).